Biomonitoring Equivalents (BEs) for tetrabromobisphenol A

被引:9
|
作者
Hays, Sean M. [1 ]
Kirman, Christopher R. [1 ]
机构
[1] Summit Toxicol LLB, Bozeman, MT 59715 USA
关键词
Biomonitoring Equivalents; Risk assessment; Pharmacokinetics; Tetrahromobisphenol A; POLYBROMINATED DIPHENYL ETHERS; SOLID-PHASE EXTRACTION; HUMAN SERUM; TOXICOKINETICS; DISPOSITION; POPULATION; GUIDELINES; KINETICS;
D O I
10.1016/j.yrtph.2018.12.014
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Tetrabromobisphenol A (TBBPA) is a flame retardant used in a variety of products, including epoxy and polycarbonate resins. Relevant exposure to TBBPA has been assessed by measuring TBBPA in the blood of humans. Here, we derive Biomonitoring Equivalents (BEs) for TBBPA to interpret these, and future biomonitoring results for TBBPA in humans. The available toxicity risk values (TRVs) for TBBPA were all based on toxicology studies in rats. Several studies have been conducted in which TBBPA in blood of rats were measured following controlled oral doses of TBBPA. These data provide a robust relationship from which to derive BEs. BEs of 5.6 and 13.0 mu g total TBBPA/L plasma were calculated for available cancer and non-cancer TRVs, respectively. Several studies have measured TBBPA in serum, with median concentrations less than 0.1 mu g/L, indicating considerable margins of safety (MOS) for TBBPA based on the currently available biomonitoring studies.
引用
收藏
页码:108 / 114
页数:7
相关论文
共 50 条
  • [21] Derivation of biomonitoring equivalents (BE values) for bismuth
    Poddalgoda, Devika
    Hays, Sean M.
    Nong, Andy
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 114
  • [22] Biomonitoring Equivalents for interpretation of urinary fluoride
    Aylward, L. L.
    Hays, S. M.
    Vezina, A.
    Deveau, M.
    St-Amand, A.
    Nong, A.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 72 (01) : 158 - 167
  • [23] Derivation of biomonitoring equivalents (BE values) for zinc
    Poddalgoda, Devika
    Macey, Kristin
    Hancock, Scott
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2019, 106 : 178 - 186
  • [24] Biomonitoring Equivalents for interpretation of urinary iodine
    Hays, Sean M.
    Poddalgoda, Devika
    Macey, Kristin
    Aylward, Lesa
    Nong, Andy
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2018, 94 : 40 - 46
  • [25] Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring data
    Ramoju, S.
    Andersen, M. E.
    Nong, A.
    Karyakina, N.
    Shilnikova, N.
    Krishnan, K.
    Krewski, D.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 114
  • [26] Biomonitoring Equivalents for interpretation of silver biomonitoring data in a risk assessment context
    Aylward, Lesa L.
    Bachler, Gerald
    von Goetz, Natalie
    Poddalgoda, Devika
    Hays, Sean M.
    Nong, Andy
    INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2016, 219 (06) : 521 - 526
  • [27] Derivation of whole blood biomonitoring equivalents for lithium for the interpretation of biomonitoring data
    Ramoju, S.
    Andersen, M.
    Poddalgoda, D.
    Nong, A.
    Karyakina, N.
    Shilnikova, N.
    Krishnan, K.
    Krewski, D.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 111
  • [28] Derivation of Biomonitoring Equivalents for aluminium for the interpretation of population-level biomonitoring data
    Poddalgoda, Devika
    Hays, Sean M.
    Kirman, Chris
    Chander, Natasha
    Nong, Andy
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2021, 122
  • [29] Development of biomonitoring equivalents for barium in urine and plasma for interpreting human biomonitoring data
    Poddalgoda, Devika
    Macey, Kristin
    Assad, Henry
    Krishnan, Kannan
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2017, 86 : 303 - 311
  • [30] A Review on Tetrabromobisphenol A: Human Biomonitoring, Toxicity, Detection and Treatment in the Environment
    Miao, Baoji
    Yakubu, Salome
    Zhu, Qingsong
    Issaka, Eliasu
    Zhang, Yonghui
    Adams, Mabruk
    MOLECULES, 2023, 28 (06):